PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
Washington, D.C.; PAHO; 2020-07-16. (PAHO/IMS/PHE/COVID-19/20-0040).
in En
| PAHOIRIS
| ID: phr-52515
Responsible library:
US1.1
ABSTRACT
PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.
Full text:
1
Collection:
04-international_org
Database:
PAHOIRIS
Main subject:
Coronavirus
/
Chlorine Dioxide
/
Pandemics
/
COVID-19
Language:
En
Year:
2020